Clinical trials: Intravenous Baclofen

Intravenous Baclofen

Repeated Dose IV Baclofen Safety/Bioequivalence Study

• Unknown status
• Age: 18 to 45 years
• Phase 1/2
• Pill or oral medicine
• Injection or infusion

The purpose of this study is to identify a suitable dosing regimen of IV baclofen to serve as a temporary substitute for an oral regimen.

Trial name

NCT02760992

Testing

IV Baclofen, Oral Baclofen

Volunteers

42 people, healthy volunteers welcome

Sponsor

Allaysis, LLC